FDA approves CBI-1214 for colorectal cancer, enabling fast-tracked clinical trials and highlighting innovative T-cell engager ...
When Adam Herbert talks about the origins of his business, he doesn’t refer to a boardroom, a pitch deck or a venture capital ...